期刊文献+

T—bet质粒基因转染对哮喘小鼠支气管肺泡灌洗液白细胞介素13和内皮素1的影响 被引量:2

Effect of intranasal T-bet plasmid transfer on bronchial alveolar lavage fluid IL-13 and ET-1 in a murine asthmatic model
原文传递
导出
摘要 目的 观察气道内T-bet质粒基因转染对哮喘小鼠气道肺泡灌洗液白细胞介素13(IL13)、内皮素1(ET-1)的影响.方法 C57BL/6J小鼠32只,完全随机分为4组(n=8),即哮喘模型组(A组)、正常对照组(B组)、空质粒干预组(C组)和模型T-bet质粒干预组(D组).用卵白蛋白(OVA)抗原溶液小鼠腹腔注射致敏,滴鼻造模.B组用生理盐水代替卵白蛋白,C组和D组卵白蛋白激发48 h前,分别经鼻滴入50μg空质粒或重组T-bet质粒.免疫印迹检测和酶联免疫吸附法(ELISA)检测各组小鼠的支气管肺泡灌洗液中IL-13、ET-1的水平.结果 哮喘模型组小鼠支气管肺泡灌洗液(BALF)中Th2因子IL-13和ET-1水平比正常对照组升高[(2.32±0.40)ng/L比(0.38±0.16)ng/L,(40.07±6.52)ng/L比(14.16±0.51)ng/L,均P<0.05];模型T-bet质粒干预组BALF中Th2因子IL-13和ET-1水平[(1.16±0.19)和(23.08±2.59)ng/L]比哮喘模型组降低(均P<0.05).结论 气道内转染T-bet质粒能有效下调小鼠BALF中Th2因子IL-13及ET-1水平. Objective To investigate the effects of airway T-bet plasmid gene transfer on IL-13 and ET-1 in bronchial alveolar lavage fluid (BALF) of murine asthmatic model. Methods Thirty-two C57BL/6J mice were randomized into four groups (8 mice each):the asthmatic model group (group A) , the normal control group (group B) , the pcDNA3 plasmid group (group C) and the pcDNA3-T-bet group (group D). The mouse asthma model was established by sensitization with intraperitoneal injection of ovalbumin (OVA) and intranasal challenge in all animals except for the group B where normal saline was used instead. At 48 hours before intranasal challenges, the group C was intranasally administered 50 μg pcDNA3 plasmid, and the group D with 50μg pcDNA3-T-bet plasmid.At 48 hours after OVA challenge, BALF was collected for determination of IL-13 and ET-1 levels by immunoblotting and ELISA. Results The levels of IL-13 and ET1 in BALF were significantly elevated in the asthmatic model group compared with the normal control group [(2.32±0.40)ng/L vs (0.38±0.16)ng/L,(40.07±6.52)ng/L vs (l4.16±0.5l)ng/L, both P〈0.05), and were lowered in the pcDNA3-T-bet group[(1.16±0.19)ng/L and (23.08±2.59)ng/L, respectively] compared with the asthmatic model group (both P〈0.05). Conclusion Intranasal pcDNA3-T-bet plasmid transfer can reduce the levels of IL-13 and ET-1 in BALF of the murine asthmatic model.
出处 《中华生物医学工程杂志》 CAS 2011年第2期120-123,共4页 Chinese Journal of Biomedical Engineering
基金 基金项目:广东省自然科学基金(06021301A) 广东省科委科技计划项目(20078030704004) 2009年度广东省自然科学基金资助博士科研启动项目(9451008901003)
关键词 支气管肺泡灌洗液 哮喘 T-BET基因 白介素13 内皮素1 Bronchoalveolar lavage fluid Asthma T - bet genes Interleukin 13 Endothelin 1
  • 相关文献

参考文献18

  • 1李伟杰.哮喘的基因治疗[J].国外医学(呼吸系统分册),2000,20(1):1-3. 被引量:26
  • 2Gill DR, Davies LA, Pringle IA, et al. The development of gene therapy for diseases of the lung. Cell Mol Life Sei, 2004, 61: 355-368.
  • 3Gautam A, Waldrep C J, Densmore CL. Delivery systems for pulmonary gene therapy. Am J Respir Med, 2002, 1 : 35-46.
  • 4檀卫平,麦贤弟,吴葆菁,李晓圆,李静,魏菁,黄花荣,黄绍良.哮喘患儿转录因子T-bet/GATA-3 mRNA表达及其与杀伤性T淋巴细胞平衡间的关系[J].中华儿科杂志,2007,45(4):284-287. 被引量:10
  • 5Finotto S, Neurath MF, Glickman JN, et al. Development of spontaneous airway changes consistant with human asthma in mice lacking T-bet. Science, 2002, 295: 336-338.
  • 6Szabo SJ, Kim ST, Costa GL, et al. A novel transcription factor, T-bet, directs Thl lineage commitment. Cell, 2000, 100: 655- 669.
  • 7Mullen AC, High FA, Hutchins AS, et al. Role of T-bet in commitment of Thl cells before IL-12-dependent selection. Science, 2001, 292: 1907-1910.
  • 8Hancock A, Armstrong L, Gama R, et al. Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung. Am J Respir Cell Mol Biol, 1998, 18: 60- 65.
  • 9Yanagisawa M, Kurihara H, Kimura S, et al. A nove potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 1998, 332: 411-415.
  • 10陈兴无,徐军.内皮素在诱导人气管上皮下成纤维细胞转分化中的作用[J].中国病理生理杂志,2007,23(6):1125-1129. 被引量:4

二级参考文献34

  • 1黄培堂 译 EF弗里奇 T曼尼阿蒂斯 主编.分子克隆实验指南:第3版[M].北京:科学出版社,2002.26-36.
  • 2J·萨姆布鲁克 黄培堂 译.分子克隆实验指南(第3版)[M].北京:科学出版社,2002.492-499.
  • 3Szabo SJ, Kim ST, Costa GL, et al. A novel transcription factor, T-bet, direct Th1 lineage commitment. Cell,2000,100(6) :655.
  • 4Finotto S, Neurath MF, Glickman JN, et al. Development of spontaneous airway changes consistant with human asthma in mice lacking T - bet.Science, 2002,295(5553) :336.
  • 5Finotto S, Glimcher L. T cell directives for transcriptional regulation in asthma. Springer Semin Immunopathol, 2004,25 (3-4): 281-294.
  • 6Kay A. The role of T lymphocytes in asthma. Chem Immunol Allergy ,2006, 91:59-75.
  • 7O'Sullivan S, Comfican L, Faul JL, et al. Activated, cytotoxic CD8 ( + ) T lymphocytes contribute to the pathology of asthma death. Am J Respir Crit Care Med, 2001,164:560-564.
  • 8Fu CL, Ye YL, Lee YL, et al. Both allergen-specific CD4 and CD8 Type 2 T cells decreased in asthmatic children with immunotherapy. Pediatr Allergy Immunol, 2003,14:284-291.
  • 9Sawicka E, Noble A, Walker, et al. Tc2 cells respond to soluble antigen in the respiratory tract and induce lung eosinophilia and bronchial hyperresponsiveness. Eur J Immunol, 2004,34 : 2599-2608.
  • 10Chakir H, Wang H, Lefebvre DE, et al. T-bet/GATA-3 ratio as a measure of the TH1/ TH2 cytokine profile in mixed cell populations: predominant role of GATA-3. J Immunol Methods,2003, 278(1-2) :157-169.

共引文献46

同被引文献18

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部